Skip to content
Bonus Club US

Zimbabwe Declines ‘One-Sided’ US Health Aid Deal Due to Information Fears

Medical funding illustration
The offered US financial assistance was aimed at initiatives for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has declined a significant US healthcare agreement valued at $367m (272 million pounds) spanning five years due to Washington's demand for sensitive biological samples.

This rejection became public after a government memo dated December was leaked, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".

An official spokesman later clarified that the US was demanding access to biological samples for scientific study and commercial purposes but was not willing to guarantee the benefits from any future treatments.

"We will now turn to the challenging and unfortunate task of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy said the US had furnished over $1.9bn for health programmes to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has called for further negotiations to find a agreement agreeable to both sides so the nation's vital HIV treatment initiative can continue.

Wider Context

This development comes after a comparable situation in neighbouring Kenya, where a court blocked a related health funding agreement after legal challenges were raised about the security of citizens' health data.

Since resuming office last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.

USAID had managed aid for the American government, but Trump argued its expenditure was "inefficient" and his government was pursuing government-to-government agreements to boost transparency and responsibility.

As per reports, 16 nations in Africa have so far agreed to similar health pacts, constituting over $18.3bn of fresh investment.

Specifics of the Declined Deal

This assistance for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this partnership would have delivered immense advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving antiretroviral therapy via US-supported initiatives," the Ambassador commented.

However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".

"Our nation was requested to provide its biological resources and data over an extended period, without any corresponding promise of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.

"In essence, our country would provide the raw materials for medical research without any assurance that the resulting innovations would be accessible to our citizens should a new disease outbreak emerge."

Sovereignty and International Frameworks

Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting structures already established through the international organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to manage potential pandemics.

"This system is intended to ensure that when a country contributes its data, the benefits – including vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to create them."

These objections over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.

"We encourage continued discussions with our American counterparts on how future collaboration could be structured in a way that respects the independence and dignity of each country."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but urged that negotiations need to persist considering a large portion of the country's Aids initiatives relied on foreign aid.

"If specific concerns arise, including those relating to information security or agreement terms, these can often be addressed through detailed discussion and negotiated safeguards," the group said.

The halted deal emphasises the complex challenges between accepting crucial international aid and safeguarding a country's data in an ever more interconnected world.

About the author

Laura Johnson

Elara is a seasoned deal hunter and rewards expert, passionate about helping others maximize their savings through smart shopping strategies.

Bonus Club US

Type to search articles.